Intro

This chapter explores the economics behind GLP-1 agonist drugs and the pivotal role of compounding pharmacies in their distribution. It highlights how these pharmacies are exploiting legal loopholes to provide patients with access to medications during national shortages, circumventing limitations imposed by traditional pharmaceutical companies.